4 December 2015 - Deborah Wilkes
Archived
The European Union's Pharmacovigilance Risk Assessment Committee (PRAC) has provided an update on its review of the safety and benefit-risk balance of nasal and mouth sprays containing the antibiotic fusafungine.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.